SCHEMBL4318402

SCHEMBL4318402

NC(=O)Oc1ccccc1-c1cccs1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
MAPT P10636 3/20 0.46
GAA P10253 2/20 0.46
HPGD P15428 2/20 0.46
KDM4E B2RXH2 2/20 0.46
TSHR P16473 1/20 0.46
HSD17B10 Q99714 1/20 0.46
TMIGD3 P0DMS9 2/20 0.42
ADORA2A P29274 1/20 0.42
AR P10275 1/20 0.41
KMT2A Q03164 1/20 0.41
ADRA1D P25100 1/20 0.41
ADRA1A P35348 1/20 0.41
ADRA1B P35368 1/20 0.41
KEAP1 Q14145 1/20 0.40
ADRA2A P08913 1/20 0.39
ADRA2B P18089 1/20 0.39
ADRA2C P18825 1/20 0.39
ERN1 O75460 1/20 0.39
BAZ2B Q9UIF8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4048688 0.83 TMIGD3 (0.58) ALDH1A1MAPTGAAHPGDKDM4E
SCHEMBL28007810 0.81 BCAT2 (0.40) ALDH1A1MAPTGAAHPGDKDM4E
SCHEMBL29728528 0.80 KMT2A (0.46) ALDH1A1MAPTHPGDKDM4ETSHR
SCHEMBL9796762 0.76 ADRA1D (0.48) ALDH1A1MAPTHPGDKDM4EKMT2A
SCHEMBL3827285 0.75 MAPT (0.42) ALDH1A1MAPTGAAHPGDKDM4E
SCHEMBL3559657 0.74 ALDH1A1 (0.54) ALDH1A1MAPTGAAHPGDKDM4E
SCHEMBL7029967 0.73 KMT2A (0.52) ALDH1A1MAPTHPGDKDM4ETSHR
SCHEMBL29728552 0.73 KMT2A (0.52) ALDH1A1MAPTHPGDKDM4ETSHR
SCHEMBL28744734 0.73 HPGD (0.48) ALDH1A1MAPTGAAHPGDTMIGD3
SCHEMBL4466164 0.73 ADRA1D (0.47) ALDH1A1ADORA2AKMT2AADRA1DADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904446-A2 AZABICYCLO DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS Ranbaxy Laboratories Limited (IN) 2008-04-02 EP claimed
WO-2007007282-A2 AZABICYCLO DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS RANBAXY LABORATORIES LIMITED (IN) 2007-01-18 WO claimed
CN-112759545-B 3- (dimethylamino methyl) piperidine-4-alcohol derivative and preparation method and pharmaceutical application thereof 复旦大学 2022-12-13 CN disclosed
CN-112759545-A 3- (dimethylamino methyl) piperidine-4-alcohol derivative and preparation method and pharmaceutical application thereof 复旦大学 2021-05-07 CN disclosed
CN-109721615-A Inhibitors of influenza viruses replication and application thereof 广东东阳光药业有限公司 2019-05-07 CN disclosed
WO-2009090548-A2 3-AZABICYCLO [3.1.0] HEXANE DERIVATIVES AS VANILLOID RECEPTOR LIGANDS GLENMARK PHARMACEUTICALS, S.A. (US) 2009-07-23 WO disclosed
EP-1904446-A2 AZABICYCLO DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS Ranbaxy Laboratories Limited (IN) 2008-04-02 EP disclosed
WO-2007007282-A2 AZABICYCLO DERIVATIVES AS MUSCARINIC RECEPTOR ANTAGONISTS RANBAXY LABORATORIES LIMITED (IN) 2007-01-18 WO disclosed